Phreesia (PHR) Expected to Announce Earnings on Wednesday

Phreesia (NYSE:PHR) is expected to release its Q2 2027 results after the market closes on Wednesday, September 2nd. Analysts expect the company to announce earnings of $0.0851 per share and revenue of $129.0650 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q2 2027 earning report page for the latest details on the call scheduled for Wednesday, September 2, 2026 at 5:00 PM ET.

Phreesia Trading Up 0.2%

NYSE:PHR opened at $12.17 on Monday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. The stock has a market capitalization of $752.23 million, a PE ratio of 81.13 and a beta of 0.85. The firm’s 50 day moving average is $11.03 and its 200 day moving average is $10.48. Phreesia has a 12 month low of $7.77 and a 12 month high of $32.74.

Institutional Trading of Phreesia

A number of hedge funds and other institutional investors have recently bought and sold shares of PHR. Commerce Bank increased its position in shares of Phreesia by 12.5% in the fourth quarter. Commerce Bank now owns 16,361 shares of the company’s stock worth $277,000 after purchasing an additional 1,815 shares during the last quarter. McMillan Office Inc. purchased a new stake in Phreesia in the fourth quarter valued at approximately $262,000. Virtus Advisers LLC raised its stake in Phreesia by 522.8% in the third quarter. Virtus Advisers LLC now owns 14,181 shares of the company’s stock valued at $334,000 after purchasing an additional 11,904 shares in the last quarter. State of Tennessee Department of Treasury bought a new stake in Phreesia during the second quarter valued at approximately $330,000. Finally, Globeflex Capital L P lifted its position in Phreesia by 62.3% during the second quarter. Globeflex Capital L P now owns 10,070 shares of the company’s stock valued at $287,000 after purchasing an additional 3,866 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on PHR. DA Davidson reissued a “buy” rating and set a $14.00 target price on shares of Phreesia in a report on Thursday, May 28th. Truist Financial raised their price target on Phreesia from $11.00 to $12.00 and gave the stock a “hold” rating in a report on Thursday, May 28th. Barclays reiterated an “equal weight” rating and issued a $10.00 price target (down from $24.00) on shares of Phreesia in a research report on Thursday, May 14th. Citigroup reiterated a “market perform” rating on shares of Phreesia in a research note on Friday, May 29th. Finally, Wells Fargo & Company reissued an “equal weight” rating and set a $9.00 price objective (down from $15.00) on shares of Phreesia in a report on Wednesday, May 20th. Nine investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $16.65.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.